Research location: Toronto General Hospital/Research Institute (UHN)
Primary Research Area: Molecular & Cell Biology
Secondary Research Area: Hematopathology
We are interested in studying the molecular pathogenesis of multiple myeloma (MM) and identifying prognostic and predictive biomarkers in MM. We are also interested in pre-clinical evaluation of small molecules targeting various oncogenic signaling pathways as novel therapeutic strategies in MM.